Skip to main content

Table 2 Demographic characteristics of patients admitted for percutaneous coronary intervention in selected studies

From: Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention

 

Hess et al.

Nakatsuma et al.

Landes et al. (*)

Characteristics, n (%)

Cancer

n = 496

No cancer

n = 14,512

Cancer

n = 1109

No cancer

n = 11,071

Cancer

n = 969

No cancer

n = 969

Age (years)

68 (61.8)

62 (53.7)

73.2 ± 8.5

67.8 ± 11.1

76.6 ± 10.1

76.9 ± 9.2

Men

354 (71.4)

9586 (66.1)

825 (74.4)

7976 (72)

700 (72.2)

700 (72.2)

Systemic hypertension

334 (67.3)

9478 (65.3)

904 (81.5)

9100 (82.2)

843 (87)

843 (87)

Diabetes mellitus

129 (26)

4013 (27.7)

440 (39.7)

4154 (37.5)

318 (45.7)

318 (45.7)

Hyperlipidemia

n/a

n/a

n/a

n/a

  

Active smoker

238 (48)

7712 (53.1)

230 (20.7)

3648 (33)

230 (23.7)

204 (21.1)

History of

 Myocardial infarction

246 (49.6)

7414 (51.1)

119 (10.7)

1141 (10.3)

n/a

n/a

 PCI

n/a

n/a

n/a

n/a

n/a

n/a

 CABG

n/a

n/a

n/a

n/a

185 (19.1)

196 (20.2)

 Stroke

66 (13.3)

1196 (8.2)

142 (12.8)

1149 (10.4)

87 (9)

63 (6.5)

 Anemia

n/a

n/a

228 (20.6)

1165 (10.5)

n/a

n/a

Presentation

 ACS

329 (66.6)

10,481 (72.4)

317 (28.6)

2992 (27)

592 (61.1)

527 (54.4)

Number of diseased vessels

 1 vessel

255 (55.8)

8839 (65.4)

n/a

n/a

163 (16.9)

175 (18.1)

 2 vessels

131 (28.7)

3095 (22.9)

n/a

n/a

320 (33)

310 (32)

 3 vessels

71 (15.5)

1574 (11.7)

n/a

n/a

485 (50.1)

369 (40.9)

Procedure

 Drug-eluting stent

164 (54.5)

4209 (62.1)

570 (51.4)

6218 (56.2)

392 (40.5)

465 (48)

 Bare metal stent

n/a

n/a

n/a

n/a

529 (54.6)

464 (47.9)

Treatment at discharge

 Beta-blockers

447 (90.1)

13,077 (90.1)

294 (27)

3410 (31)

n/a

n/a

 ACE/ARBs

418 (84.3)

10,992 (75.7)

571 (51)

6573 (59)

n/a

n/a

 Statins

n/a

n/a

487 (44)

5816 (53)

n/a

n/a

 Aspirin

489 (98.6)

14,355 (98.9)

1092 (98)

10,936 (99)

n/a

n/a

 P2Y12 Inhibitors

437 (88.1)

11,023 (76)

136 (13)

1018 (9.3)

n/a

n/a

  1. ACE Angiotensin-Converting Enzyme; ACS Acute Coronary Syndrome; ARBs Angiotensin Receptor Blockers; CABG Coronary Artery Bypass Grafting; PCI Percutaneous Coronary Intervention
  2. (*) data of the matched patients